Abstract

A label-free immunosensor platform based on excessively tilted fiber gratings (Ex-TFGs) was developed for highly specific and fast detection of human N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is considered a powerful biomarker for prognosis and risk stratification of heart failure (HF). High-purity anti-NT-proBNP monoclonal antibodies (MAbs) prepared in our laboratory were immobilized on fiber surface through the staphylococcal protein A (SPA) method for subsequent specific binding of the targeted NT-proBNP. Utilizing fiber optic grating demodulation system (FOGDS), immunoassays were carried out in vitro by monitoring the resonance wavelength shift of Ex-TFG biosensor with immobilized anti-NT-proBNP MAbs. Lowest detectable concentration of ~0.5ng/mL for NT-proBNP was obtained, and average sensitivity for NT-proBNP at a concentration range of 0~1.0 ng/mL was approximately 45.967 pm/(ng/mL). Several human serum samples were assessed by the proposed Ex-TFG biomarker sensor, with high specificity for NT-proBNP, indicating potential application in early diagnosing patients with acute HF symptoms.

© 2016 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
Label-free and specific detection of soluble programmed death ligand-1 using a localized surface plasmon resonance biosensor based on excessively tilted fiber gratings

Binbin Luo, Yajie Wang, Huafeng Lu, Shengxi Wu, Youming Lu, Shenghui Shi, Lingchen Li, Shanghai Jiang, and Mingfu Zhao
Biomed. Opt. Express 10(10) 5136-5148 (2019)

Biosensor based on excessively tilted fiber grating in thin-cladding optical fiber for sensitive and selective detection of low glucose concentration

Binbin Luo, Zhijun Yan, Zhongyuan Sun, Yong Liu, Mingfu Zhao, and Lin Zhang
Opt. Express 23(25) 32429-32440 (2015)

Immunosensing platform with large detection range using an excessively tilted fiber grating coated with graphene oxide

Binbin Luo, Huafeng Lu, Shenghui Shi, Jiao Lu, Mingfu Zhao, Shengxi Wu, Lingchen Li, Xin Wang, and Yajie Wang
Appl. Opt. 57(30) 8805-8810 (2018)

References

  • View by:
  • |
  • |
  • |

  1. S. K. Arya and S. Bhansali, “Lung cancer and its early detection using biomarker-based biosensors,” Chem. Rev. 111(11), 6783–6809 (2011).
    [Crossref] [PubMed]
  2. J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).
  3. J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
    [Crossref] [PubMed]
  4. S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
    [Crossref] [PubMed]
  5. J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
    [Crossref]
  6. R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
    [Crossref] [PubMed]
  7. K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
    [Crossref] [PubMed]
  8. K. Qin, S. Hu, S. T. Retterer, I. I. Kravchenko, and S. M. Weiss, “Slow light Mach-Zehnder interferometer as label-free biosensor with scalable sensitivity,” Opt. Lett. 41(4), 753–756 (2016).
    [Crossref] [PubMed]
  9. H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
    [Crossref] [PubMed]
  10. J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
    [Crossref]
  11. F. Dell’Olio, D. Conteduca, C. Ciminelli, and M. N. Armenise, “New ultrasensitive resonant photonic platform for label-free biosensing,” Opt. Express 23(22), 28593–28604 (2015).
    [Crossref] [PubMed]
  12. G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
    [Crossref] [PubMed]
  13. K. Zhou, L. Zhang, X. Chen, and I. Bennion, “Optic sensors of high refractive-index responsivity and low thermal cross sensitivity that use fiber Bragg gratings of >80 ° tilted structures,” Opt. Lett. 31(9), 1193–1195 (2006).
    [Crossref] [PubMed]
  14. T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
    [Crossref] [PubMed]
  15. T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
    [Crossref] [PubMed]
  16. J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
    [Crossref] [PubMed]
  17. L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
    [Crossref] [PubMed]
  18. M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).
  19. P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
    [Crossref] [PubMed]
  20. C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
    [Crossref] [PubMed]
  21. K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
    [Crossref] [PubMed]
  22. Z. Yan, H. Wang, C. Wang, Z. Sun, G. Yin, K. Zhou, Y. Wang, W. Zhao, and L. Zhang, “Theoretical and experimental analysis of excessively tilted fiber gratings,” Opt. Express 24(11), 12107–12115 (2016).
    [Crossref] [PubMed]
  23. B. Luo, Z. Yan, Z. Sun, J. Li, and L. Zhang, “Novel glucose sensor based on enzyme-immobilized 81° tilted fiber grating,” Opt. Express 22(25), 30571–30578 (2014).
    [Crossref] [PubMed]
  24. X. W. Shu, L. Zhang, and I. Bennion, “Sensitivity characteristics of long-period fiber gratings,” J. Lightwave Technol. 20(2), 255–266 (2002).
    [Crossref]
  25. J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
    [Crossref] [PubMed]
  26. M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
    [Crossref] [PubMed]
  27. Z. Yan, Z. Sun, K. Zhou, B. Luo, J. Li, H. Wang, Y. Wang, W. Zhao, and L. Zhang, “Numerical and experimental analysis of sensitivity-enhanced RI sensor based on Ex-TFG in thin cladding Fiber,” J. Lightwave Technol. 33(14), 3023–3027 (2015).
    [Crossref]

2016 (3)

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

K. Qin, S. Hu, S. T. Retterer, I. I. Kravchenko, and S. M. Weiss, “Slow light Mach-Zehnder interferometer as label-free biosensor with scalable sensitivity,” Opt. Lett. 41(4), 753–756 (2016).
[Crossref] [PubMed]

Z. Yan, H. Wang, C. Wang, Z. Sun, G. Yin, K. Zhou, Y. Wang, W. Zhao, and L. Zhang, “Theoretical and experimental analysis of excessively tilted fiber gratings,” Opt. Express 24(11), 12107–12115 (2016).
[Crossref] [PubMed]

2015 (3)

2014 (1)

2013 (3)

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

2011 (1)

S. K. Arya and S. Bhansali, “Lung cancer and its early detection using biomarker-based biosensors,” Chem. Rev. 111(11), 6783–6809 (2011).
[Crossref] [PubMed]

2009 (1)

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

2008 (3)

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
[Crossref] [PubMed]

2007 (3)

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

2006 (1)

2005 (2)

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

2004 (2)

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

2002 (2)

X. W. Shu, L. Zhang, and I. Bennion, “Sensitivity characteristics of long-period fiber gratings,” J. Lightwave Technol. 20(2), 255–266 (2002).
[Crossref]

R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
[Crossref] [PubMed]

1993 (1)

M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).

1972 (1)

J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
[Crossref] [PubMed]

Apple, F. S.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Armenise, M. N.

Arya, S. K.

S. K. Arya and S. Bhansali, “Lung cancer and its early detection using biomarker-based biosensors,” Chem. Rev. 111(11), 6783–6809 (2011).
[Crossref] [PubMed]

Barnes, S. C.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Bennion, I.

Bhansali, S.

S. K. Arya and S. Bhansali, “Lung cancer and its early detection using biomarker-based biosensors,” Chem. Rev. 111(11), 6783–6809 (2011).
[Crossref] [PubMed]

Bogers, A. J.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Boniello, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Borriello, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Brandenburg, A.

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

Cao, J.

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

Chen, S.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Chen, X.

Chen-Tournoux, A. A.

J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
[Crossref] [PubMed]

Ciminelli, C.

Clerico, A.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Colao, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Collinson, P. O.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Consales, M.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Conteduca, D.

Cusano, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Cutolo, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Dell’Olio, F.

Diodato, L.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Dobson, A.

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

Doust, J. A.

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

Emdin, M.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Erdene, N.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Esakova, T. V.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Fernández-Lahore, M.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Filatov, V. L.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Frampton, C. M.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Fu, Z.

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

Galasko, G.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Galema, T. W.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Gaze, D. C.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Gegenhuber, A.

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

Geleijnse, M. L.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Giordano, M.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Glasziou, P.

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

Gorrepati, K. D.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Grasselli, M.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Grattan, K. T. V.

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

Haltmayer, M.

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

Hjelm, H.

J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
[Crossref] [PubMed]

Hoffmann, C.

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

Hu, C.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Hu, S.

Januzzi, J. L.

J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
[Crossref] [PubMed]

Jeong, D. H.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Jeong, H. H.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Ju, H.

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

Kangwa, M.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Kara, A. N.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Katrukha, A. G.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Kono, M.

M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).

Koshkina, E. V.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Krasnoselsky, M. I.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Kravchenko, I. I.

Lahiri, A.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Lee, H. Y.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Lee, S. K.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Lewis, L. K.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Li, J.

Li, J. S.

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

Li, P.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Li, S.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Lindemans, J.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Luo, B.

Macchia, P. E.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Mazzarella, C.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Meloun, B.

J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
[Crossref] [PubMed]

Meyrueis, P.

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

Moe, G.

J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
[Crossref] [PubMed]

Mueller, T.

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

Mukharyamova, K. S.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Mutlu, S.

R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
[Crossref] [PubMed]

Nettore, I. C.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Palmer, S. C.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Park, J. H.

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

Pietrzak, E.

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

Piskin, E.

R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
[Crossref] [PubMed]

Poelz, W.

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

Polat, A. N.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Prontera, C.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Qin, K.

Quero, G.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Raudsepp, S. D.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Retterer, S. T.

Richards, A. M.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Roos-Hesselink, J. W.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Ruvo, M.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Saber, R.

R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
[Crossref] [PubMed]

Sandomenico, A.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Santorelli, F.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Schirmer, B.

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

Schmitt, K.

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

Seferian, K. R.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Semenov, A. G.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Senior, R.

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Severino, R.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Shen, G. L.

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

Shu, X. W.

Simoons, M. L.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Sjöquist, J.

J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
[Crossref] [PubMed]

Storti, S.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Su, S.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Sun, T.

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

Sun, Z.

Tamm, N. N.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

ten Cate, F. J.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Tolstaya, A. A.

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Troughton, R. W.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Tsuji, T.

M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).

Tu, M. H.

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

Vaiano, P.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

van Thiel, R. J.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Vittorini, S.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Wang, C.

Wang, H.

Wang, Y.

Weiss, S. M.

Wu, J.

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

Wu, Z. S.

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

Yamauchi, A.

M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).

Yan, F.

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

Yan, Z.

Yandle, T. G.

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Yap, S. C.

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

Yelemane, V.

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Yi, W.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Yin, G.

Yu, R.

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

Zhang, L.

Zhang, R.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Zhang, Z.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Zhao, L.

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

Zhao, W.

Zhou, K.

Zucchelli, G. C.

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Zuppolini, S.

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

Am. J. Cardiol. (1)

J. L. Januzzi, A. A. Chen-Tournoux, and G. Moe, “Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms,” Am. J. Cardiol. 101(3Supplement), 29–38 (2008).
[Crossref] [PubMed]

AMB Express (1)

M. Kangwa, V. Yelemane, A. N. Polat, K. D. Gorrepati, M. Grasselli, and M. Fernández-Lahore, “High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization,” AMB Express 5(1), 70–79 (2015).
[Crossref] [PubMed]

Biosens. Bioelectron. (4)

H. H. Jeong, N. Erdene, J. H. Park, D. H. Jeong, H. Y. Lee, and S. K. Lee, “Real-time label-free immunoassay of interferon-gamma and prostate-specific antigen using a Fiber-Optic Localized Surface Plasmon Resonance sensor,” Biosens. Bioelectron. 39(1), 346–351 (2013).
[Crossref] [PubMed]

G. Quero, M. Consales, R. Severino, P. Vaiano, A. Boniello, A. Sandomenico, M. Ruvo, A. Borriello, L. Diodato, S. Zuppolini, M. Giordano, I. C. Nettore, C. Mazzarella, A. Colao, P. E. Macchia, F. Santorelli, A. Cutolo, and A. Cusano, “Long period fiber grating nano-optrode for cancer biomarker detection,” Biosens. Bioelectron. 80, 590–600 (2016).
[Crossref] [PubMed]

R. Saber, S. Mutlu, and E. Pişkin, “Glow-discharge treated piezoelectric quartz crystals as immunosensors for HSA detection,” Biosens. Bioelectron. 17(9), 727–734 (2002).
[Crossref] [PubMed]

K. Schmitt, B. Schirmer, C. Hoffmann, A. Brandenburg, and P. Meyrueis, “Interferometric biosensor based on planar optical waveguide sensor chips for label-free detection of surface bound bioreactions,” Biosens. Bioelectron. 22(11), 2591–2597 (2007).
[Crossref] [PubMed]

BMJ (1)

J. A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou, “How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review,” BMJ 330(7492), 625–632 (2005).
[Crossref] [PubMed]

Chem. Rev. (1)

S. K. Arya and S. Bhansali, “Lung cancer and its early detection using biomarker-based biosensors,” Chem. Rev. 111(11), 6783–6809 (2011).
[Crossref] [PubMed]

Clin. Biochem. (1)

L. K. Lewis, S. D. Raudsepp, T. G. Yandle, C. M. Frampton, S. C. Palmer, R. W. Troughton, and A. M. Richards, “Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA,” Clin. Biochem. 46(4-5), 388–390 (2013).
[Crossref] [PubMed]

Clin. Chem. (1)

K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, V. L. Filatov, and A. G. Katrukha, “The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure,” Clin. Chem. 53(5), 866–873 (2007).
[Crossref] [PubMed]

Clin. Chem. Lab. Med. (1)

T. Mueller, A. Gegenhuber, W. Poelz, and M. Haltmayer, “Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP),” Clin. Chem. Lab. Med. 42(2), 159–163 (2004).
[Crossref] [PubMed]

Clin. Chim. Acta (1)

C. Prontera, G. C. Zucchelli, S. Vittorini, S. Storti, M. Emdin, and A. Clerico, “Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP,” Clin. Chim. Acta 400(1-2), 70–73 (2009).
[Crossref] [PubMed]

Eur. J. Biochem. (1)

J. Sjöquist, B. Meloun, and H. Hjelm, “Protein A isolated from Staphylococcus aureus after digestion with lysostaphin,” Eur. J. Biochem. 29(3), 572–578 (1972).
[Crossref] [PubMed]

Eur. J. Heart Fail. (1)

P. O. Collinson, S. C. Barnes, D. C. Gaze, G. Galasko, A. Lahiri, and R. Senior, “Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers,” Eur. J. Heart Fail. 6(3), 365–368 (2004).
[Crossref] [PubMed]

Int. Immunopharmacol. (1)

S. Li, R. Zhang, P. Li, W. Yi, Z. Zhang, S. Chen, S. Su, L. Zhao, and C. Hu, “Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor,” Int. Immunopharmacol. 8(6), 859–865 (2008).
[Crossref] [PubMed]

J. Am. Soc. Echocardiogr. (1)

T. W. Galema, S. C. Yap, M. L. Geleijnse, R. J. van Thiel, J. Lindemans, F. J. ten Cate, J. W. Roos-Hesselink, A. J. Bogers, and M. L. Simoons, “Early detection of left ventricular dysfunction by Doppler tissue imaging and N-terminal pro-B-type natriuretic peptide in patients with symptomatic severe aortic stenosis,” J. Am. Soc. Echocardiogr. 21(3), 257–261 (2008).
[Crossref] [PubMed]

J. Lightwave Technol. (2)

Kaku Igaky (1)

M. Kono, A. Yamauchi, and T. Tsuji, “An immunoradiometric assay for brain natriuretic peptide in human plasmal,” Kaku Igaky 13, 2–7 (1993).

Opt. Express (3)

Opt. Lett. (2)

Sens. Actuators B Chem. (2)

J. Cao, M. H. Tu, T. Sun, and K. T. V. Grattan, “Wavelength-based localized surface Plasmon resonance optical fiber biosensor,” Sens. Actuators B Chem. 181, 611–619 (2013).
[Crossref]

J. S. Li, Z. S. Wu, H. Wang, G. L. Shen, and R. Yu, “A reusable capacitive immunosensor with a novel immobilization procedure based on 1, 6-hexanedithiol and nano-Au self-assembled layers,” Sens. Actuators B Chem. 110(2), 327–334 (2005).
[Crossref]

TrAC-Trend in Anal.Chem (1)

J. Wu, Z. Fu, F. Yan, and H. Ju, “Biomedical and clinical applications of immunoassays and immunosensors for tumor markers,” TrAC-Trend in Anal.Chem 26, 679–688 (2007).

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (6)

Fig. 1
Fig. 1 (a) Experimental setup, Inset: micrograph of the Ex-TFG’s core region. (b) Transmission spectrum of a fabricated Ex-TFG with the fast-axis polarized mode at 1550~1558 nm region fully excited, and (c) corresponding RI and temperature properties.
Fig. 2
Fig. 2 Preparation and purification of NT-proBNP MAbs. (a) Amplification of the NT-proBNP gene by PCR. Lane 1: PCR product from the NT-proBNP gene. (b) Identification of recombinant vector by restriction endonuclease analysis. Lane 1: T3P × 4-pET20b before digestion; Lane 2: T3P × 4-pET20b digested by NdeI and Xhol. (c) Identification of NT-proBNP by SDS-PAGE. Lane 1: NT-proBNP expressed in E. coli transformed with the T3P × 4-pET20b vector induced by IPTG; Lane 2: NT-proBNP purified by Ni affinity chromatography. (d) SDS-PAGE analysis of purified NT-proBNP MAbs from the ascetic fluid. Lane 1: Purified NT-proBNP MAbs. Heavy and light chains are shown. (e) Identification of NT-proBNP MAbs by Western-blot. Lane 1-2: NT-proBNP purified by Protein G affinity chromatography.
Fig. 3
Fig. 3 Chemical bonds of (a) APTES, (b) SPA, and (c) anti-NT-proBNP MAbs on the fiber surface.
Fig. 4
Fig. 4 (a) Spectrum evolution for an Ex-TFG and (b) the corresponding wavelength shift in every step of the surface modification.
Fig. 5
Fig. 5 Micrographs for surface morphology of (a) bare, (b) silanized, and (c) SPA-modified fibers, observed by SEM. (d) Fluorescent micrograph of the FITC-labeled-SPA modified fiber obtained by inverted fluorescence microscopy.
Fig. 6
Fig. 6 (a) Spectrum evolution for one of the Ex-TFG immunosensors as NT-proBNP levels change from 0~1000 ng/mL. (b) Average wavelength shifts for the first (‘S1’) and second (‘S2’) groups of Ex-TFGs. Relative standard deviation (RSD) from several independent measurements: 0.032 < RSD < 0.222 for ‘S1’ and 0.045 < RSD < 0.250 for ‘S2’; Inset: Magnified picture at the concentration range of 0~1.0 ng/mL.

Tables (1)

Tables Icon

Table 1 NT-proBNP Level in Serum Samples Analyzed by an Ex-TFG Immunosensor (‘S1’)

Equations (1)

Equations on this page are rendered with MathJax. Learn more.

λ cocl =( n co eff n cl,m eff ) Λ G /cosθ.

Metrics